Vestal Point Capital, LP

NEW YORK, NY · CIK 1974915 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2023 · limited partnership

Assets managed$5.5bn
Staff11 · 8 in investment roles
Main clients (by assets)Private funds 51%
Private funds1 (1 hedge) · $2.8bn gross assets
Websitevestalpoint.com
Form ADV · 2026-03-31SEC adviser record

Legal entityVestal Point Capital, LP (US)

$4.3bn reported value +19.6% vs Q1 2026

68positions

50.3%in top 10

11 new 31 added 21 reduced 33 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	BIOMARIN PHARMACEUTICAL INC COM BMRN	BMRN	6,025,000	$344.8m8.06%	8.06%	Added +2.5m	+2,450,000 68.5%
2	NEUROCRINE BIOSCIENCES INC COM NBIX	NBIX	1,880,000	$316.8m7.40%	7.40%	Added +630.0k	+630,000 50.4%
3	ABIVAX SA SPONSORED ADS ABVX	ABVX	2,349,443	$313.1m7.32%	7.32%	Added +849.4k	+849,443 56.6%
4	UNITED THERAPEUTICS CORP DEL COM UTHR	UTHR	435,000	$235.7m5.51%	5.51%	Added +360.0k	+360,000 480.0%
5	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	4,000,000	$203.0m4.74%	4.74%	Added +750.0k	+750,000 23.1%
6	NURIX THERAPEUTICS INC COM NRIX	NRIX	8,050,000	$195.3m4.56%	4.56%	Added +1.6m	+1,550,000 23.9%
7	BICARA THERAPEUTICS INC COM BCAX	BCAX	5,250,000	$155.9m3.64%	3.64%	Reduced -175.0k	-175,000 -3.2%
8	TAYSHA GENE THERAPIES INC COM SHS TSHA	TSHA	19,415,000	$132.2m3.09%	3.09%	Added +1.4m	+1,415,000 7.9%
9	ARROWHEAD PHARMACEUTICALS IN COM ARWR	ARWR	1,575,000	$128.4m3.00%	3.00%	Reduced -700.0k	-700,000 -30.8%
10	ABBOTT LABS COM ABT	ABT	1,400,000	$127.0m2.97%	2.97%	New
11	ZIMMER BIOMET HOLDINGS INC COM ZBH	ZBH	1,400,000	$120.5m2.82%	2.82%	Added +1.2m	+1,210,000 636.8%
12	DISC MEDICINE INC COM IRON	IRON	1,550,000	$113.4m2.65%	2.65%	Added +850.0k	+850,000 121.4%
13	MONTE ROSA THERAPEUTICS INC COM GLUE	GLUE	4,600,000	$111.3m2.60%	2.60%	Added +996.5k	+996,535 27.6%
14	INSULET CORP COM PODD	PODD	670,000	$102.0m2.38%	2.38%	Added +619.4k	+619,399 1224.1%
15	ASCENDIS PHARMA A/S ORD SHS ASND	ASND	375,000	$100.0m2.34%	2.34%	New
16	ASTRAZENECA PLC ORD AZN	AZN	450,000	$85.3m1.99%	1.99%	Added +350.0k	+350,000 350.0%
17	SANOFI SPONSORED ADR SNY	SNY	2,000,000	$85.3m1.99%	1.99%	Added +600.0k	+600,000 42.9%
18	REVOLUTION MEDICINES INC COM RVMD	RVMD	450,000	$84.3m1.97%	1.97%	Reduced -1.9m	-1,925,000 -81.0%
19	BIOCRYST PHARMACEUTICALS INC COM BCRX	BCRX	8,300,000	$83.0m1.94%	1.94%	Added +1.3m	+1,275,000 18.1%
20	DYNE THERAPEUTICS INC COM DYN	DYN	3,375,000	$75.0m1.75%	1.75%	Reduced -625.0k	-625,000 -15.6%
21	NEKTAR THERAPEUTICS COM NEW NKTR	NKTR	1,000,000	$69.8m1.63%	1.63%	Added +715.0k	+715,000 250.9%
22	GLOBUS MED INC CL A GMED	GMED	850,000	$67.2m1.57%	1.57%	Added +239.5k	+239,480 39.2%
23	TARSUS PHARMACEUTICALS INC COM TARS	TARS	1,050,000	$66.1m1.54%	1.54%	Added +850.0k	+850,000 425.0%
24	IMMATICS N.V SHS IMTX	IMTX	6,175,000	$62.6m1.46%	1.46%	Unchanged
25	TREVI THERAPEUTICS INC COM TRVI	TRVI	3,100,000	$57.8m1.35%	1.35%	Added +933.5k	+933,496 43.1%
26	IMMUNOCORE HLDGS PLC ADS IMCR	IMCR	1,800,000	$57.1m1.34%	1.34%	Reduced -966.9k	-966,868 -34.9%
27	REPLIGEN CORP COM RGEN	RGEN	400,000	$54.6m1.28%	1.28%	Reduced -525.0k	-525,000 -56.8%
28	BRISTOL-MYERS SQUIBB CO COM BMY	BMY	800,000	$46.1m1.08%	1.08%	Reduced -200.0k	-200,000 -20.0%
29	UNIQURE NV SHS QURE	QURE	935,000	$43.1m1.01%	1.01%	Added +576.0k	+576,004 160.4%
30	XENON PHARMACEUTICALS INC COM XENE	XENE	700,000	$42.3m0.99%	0.99%	Added +60.1k	+60,100 9.4%
31	BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG	DRUG	545,000	$38.3m0.89%	0.89%	Added +52.7k	+52,681 10.7%
32	MADRIGAL PHARMACEUTICALS INC COM MDGL	MDGL	65,000	$34.9m0.82%	0.82%	Added +33.5k	+33,532 106.6%
33	ALCON AG ORD SHS ALC	ALC	500,000	$33.5m0.78%	0.78%	Reduced -300.0k	-300,000 -37.5%
34	MYRIAD GENETICS INC COM MYGN	MYGN	5,735,000	$32.7m0.77%	0.77%	Added +4.1m	+4,087,000 248.0%
35	RAPPORT THERAPEUTICS INC COM RAPP	RAPP	730,000	$30.4m0.71%	0.71%	Reduced -706.2k	-706,229 -49.2%
36	CRESCENT BIOPHARMA INC. COM CBIO	CBIO	1,630,000	$29.3m0.69%	0.69%	Added +130.0k	+130,000 8.7%
37	GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC	GEHC	450,000	$28.8m0.67%	0.67%	Added +200.0k	+200,000 80.0%
38	INSMED INC COM PAR $.01 INSM	INSM	250,000	$26.7m0.62%	0.62%	New
39	VIKING THERAPEUTICS INC COM VKTX	VKTX	680,000	$26.5m0.62%	0.62%	Reduced -234.1k	-234,147 -25.6%
40	BETA BIONICS INC COM BBNX	BBNX	1,600,000	$25.1m0.59%	0.59%	Reduced -611.5k	-611,518 -27.6%
41	REGENERON PHARMACEUTICALS COM REGN	REGN	40,000	$24.9m0.58%	0.58%	Unchanged
42	SOLID BIOSCIENCES INC COM NEW SLDB	SLDB	2,160,000	$21.6m0.50%	0.50%	Reduced -2.8m	-2,840,000 -56.8%
43	ALTO NEUROSCIENCE INC COM SHS ANRO	ANRO	785,000	$20.7m0.48%	0.48%	Reduced -1.3m	-1,279,075 -62.0%
44	FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX	TRAX	1,013,000	$20.4m0.48%	0.48%	New
45	LEXEO THERAPEUTICS INC COM LXEO	LXEO	4,320,000	$20.1m0.47%	0.47%	Reduced -155.0k	-155,000 -3.5%
46	SAVARA INC COM SVRA	SVRA	2,720,000	$16.8m0.39%	0.39%	Added +119.9k	+119,948 4.6%
47	DAMORA THERAPEUTICS INC COM NEW COM NEW		575,000	$15.0m0.35%	0.35%	Reduced -25.0k	-25,000 -4.2%
48	SPYGLASS PHARMA INC COM SHS SGP	SGP	670,000	$14.9m0.35%	0.35%	Added +3.2k	+3,240 0.5%
49	TECTONIC THERAPEUTIC INC COM TECX	TECX	425,000	$14.6m0.34%	0.34%	Added +97.0k	+97,000 29.6%
50	AVALO THERAPEUTICS INC COM NEW AVTX	AVTX	775,000	$14.3m0.33%	0.33%	New
51	EVOMMUNE INC COM SHS EVMN	EVMN	1,000,000	$13.3m0.31%	0.31%	New
52	KAILERA THERAPEUTICS INC COMMON STOCK KLRA	KLRA	575,000	$12.7m0.30%	0.30%	New
53	ANTERIS TECHNOLOGIES GLOBAL COM AVR	AVR	1,010,000	$9.9m0.23%	0.23%	Reduced -134.8k	-134,780 -11.8%
54	ZENAS BIOPHARMA INC COM ZBIO	ZBIO	365,000	$9.3m0.22%	0.22%	Added +165.0k	+165,000 82.5%
55	VOYAGER THERAPEUTICS INC COM VYGR	VYGR	2,625,000	$9.2m0.21%	0.21%	Reduced -377.9k	-377,936 -12.6%
56	ONKURE THERAPEUTICS INC COM CL A OKUR	OKUR	1,825,699	$8.3m0.19%	0.19%	Reduced -14.1k	-14,120 -0.8%
57	SURROZEN INC COM NEW SRZN	SRZN	304,669	$7.9m0.18%	0.18%	Reduced -33.9k	-33,942 -10.0%
58	MONOPAR THERAPEUTICS INC COM NEW MNPR	MNPR	75,727	$7.0m0.16%	0.16%	Added +10.3k	+10,309 15.8%
59	ZURA BIO LTD CLASS A ORD SHS ZURA	ZURA	1,173,956	$6.9m0.16%	0.16%	Added +663.0k	+662,956 129.7%
60	OLEMA PHARMACEUTICALS INC COM OLMA	OLMA	418,551	$5.2m0.12%	0.12%	Reduced -10.0k	-10,000 -2.3%
61	PALISADE BIO INC COM PALI	PALI	2,500,000	$5.2m0.12%	0.12%	Unchanged
62	IBIO INC COM NEW IBIO	IBIO	2,600,000	$4.5m0.11%	0.11%	New
63	SAGIMET BIOSCIENCES INC COM SER A SGMT	SGMT	535,452	$4.1m0.10%	0.10%	New
64	ENGENE THERAPEUTICS INC COM ENGN	ENGN	1,667,430	$2.9m0.07%	0.07%	New
65	REZOLUTE INC COM NEW RZLT	RZLT	382,999	$2.0m0.05%	0.05%	New
66	NYXOAH S A SHS NYXH	NYXH	843,461	$1.4m0.03%	0.03%	Reduced -25.2k	-25,200 -2.9%
67	TENAX THERAPEUTICS INC COM NEW TENX	TENX	53,439	$777.5k0.02%	0.02%	Unchanged
68	APREA THERAPEUTICS INC COM NEW APRE	APRE	350,000	$280.8k0.01%	0.01%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
APOGEE THERAPEUTICS INC		1,100,000	$92.6m1.1m shares
ASCENDIS PHARMA A/S		375,000	$85.8m375.0k shares
SCHOLAR ROCK HLDG CORP SRRK	SRRK	1,324,422	$65.1m1.3m shares
VERA THERAPEUTICS INC VERA	VERA	1,368,159	$55.0m1.4m shares
TERNS PHARMACEUTICALS INC		1,000,000	$52.7m1.0m shares
BOSTON SCIENTIFIC CORP BSX	BSX	800,000	$50.2m800.0k shares
NUVALENT INC		481,715	$49.4m481.7k shares
COGENT BIOSCIENCES INC COGT	COGT	1,230,888	$47.4m1.2m shares
CELLDEX THERAPEUTICS INC NEW CLDX	CLDX	1,224,165	$38.8m1.2m shares
KALVISTA PHARMACEUTICALS INC KALV	KALV	1,850,000	$37.2m1.9m shares
PROTAGONIST THERAPEUTICS INC PTGX	PTGX	326,159	$34.4m326.2k shares
DENALI THERAPEUTICS INC DNLI	DNLI	1,773,326	$34.0m1.8m shares
WATERS CORP WAT	WAT	100,000	$29.8m100.0k shares
INSPIRE MED SYS INC INSP	INSP	539,269	$27.8m539.3k shares
SOLENO THERAPEUTICS INC SLNO	SLNO	730,000	$24.4m730.0k shares
CYTOKINETICS INC CYTK	CYTK	300,000	$19.8m300.0k shares
WEST PHARMACEUTICAL SVSC INC WST	WST	75,000	$18.8m75.0k shares
GENEDX HOLDINGS CORP WGS	WGS	250,000	$16.1m250.0k shares
AGIOS PHARMACEUTICALS INC AGIO	AGIO	450,000	$15.2m450.0k shares
ENGENE HOLDINGS INC		2,165,000	$14.7m2.2m shares
ARVINAS INC ARVN	ARVN	905,465	$9.6m905.5k shares
MAPLIGHT THERAPEUTICS INC MPLT	MPLT	420,000	$8.5m420.0k shares
FULCRUM THERAPEUTICS INC FULC	FULC	1,100,000	$8.4m1.1m shares
CANDEL THERAPEUTICS INC CADL	CADL	1,125,000	$5.5m1.1m shares
VERACYTE INC VCYT	VCYT	130,687	$4.2m130.7k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
APREA THERAPEUTICS INC APRE · 13G · filed 2026-05-15	APRE	9.9%≈ $1.1m	new	13G	2026-05-15
TENAX THERAPEUTICS INC TENX · 13G · filed 2025-11-14	TENX	9.9%≈ $35.9m	new	13G	2025-11-14
BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15	BCAX	8.3%≈ $161.1m	+1.8 pts	13G	2026-05-15
IBIO INC IBIO · 13G · filed 2026-08-14	IBIO	7.9%≈ $7.0m	-2.0 pts	13G	2026-08-14
NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14	NRIX	7.8%≈ $195.3m	+1.5 pts	13G	2026-08-14
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2025-11-14	LXEO	7.5%≈ $19.2m	+1.5 pts	13G	2025-11-14
TAYSHA GENE THERAPIES INC TSHA · 13G · filed 2026-05-15	TSHA	6.3%≈ $122.6m	+1.3 pts	13G	2026-05-15
MYRIAD GENETICS INC MYGN · 13G · filed 2026-08-14	MYGN	6.1%≈ $32.7m	new	13G	2026-08-14
MONTE ROSA THERAPEUTICS INC GLUE · 13G · filed 2026-08-14	GLUE	5.4%≈ $111.3m	new	13G	2026-08-14
ENLIVEN THERAPEUTICS INC ELVN · 13G · filed 2026-05-15	ELVN	5.4%≈ $164.9m	-1.1 pts	13G	2026-05-15
CRESCENT BIOPHARMA INC. CBIO · 13G · filed 2026-02-17	CBIO	5.4%≈ $27.0m	new	13G	2026-02-17
BRIGHT MINDS BIOSCIENCES INC DRUG · 13G · filed 2026-05-15	DRUG	5.0%≈ $17.5m	new	13G	2026-05-15